Alterations of the tumor microenvironment in glioblastoma following radiation and temozolomide with or without bevacizumab

BACKGROUND: The immunosuppressive tumor microenvironment (TME) contributes to the tumor progression and treatment failure. Our previous study demonstrated alterations in the TME during bevacizumab (Bev) therapy in human glioblastoma (GB) specimens obtained from patients who underwent surgical resect...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Transl Med
Auteurs principaux: Tamura, Ryota, Tanaka, Toshihide, Morimoto, Yukina, Kuranari, Yuki, Yamamoto, Yohei, Takei, Jun, Murayama, Yuichi, Yoshida, Kazunari, Sasaki, Hikaru
Format: Artigo
Langue:Inglês
Publié: AME Publishing Company 2020
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7186631/
https://ncbi.nlm.nih.gov/pubmed/32355741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2020.03.11
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires